Pepto-Bismol

bismuth subsalicylate · Procter & Gamble

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pepto-Bismol, covering 2014-03-03 to 2023-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) [Phase 4]